55714-2473 NDC - LEG CRAMPS-SWELLING (ECHINACEA, ARGENTUM NITRICUM, BRYONIA, CALCAREA CARBONICA, COLOCYNTHIS, CONVALLARIA MAJALIS, CROTALUS HORRIDUS, CUPRUM METALLICUM, DIGITALIS , GELSEMIUM SEMPERVIRENS, HYPERICUM PERFORATUM, KALI CARBONICUM, LACHESIS MUTUS, LATHYRUS SATIVUS, LILIUM TIGRINUM, MAGNESIA PHOSPHORICA, NUX VOMICA, RHUS TOXICODENDRON, SILICEA, STRAMONIUM, VERATRUM VIRIDE, ELAPS)

Drug Information

  • Product NDC: 55714-2473
  • Proprietary Name: Leg Cramps-Swelling
  • Non Proprietary Name: Echinacea, Argentum nitricum, Bryonia, Calcarea carbonica, Colocynthis, Convallaria majalis, Crotalus horridus, Cuprum metallicum, Digitalis , Gelsemium sempervirens, Hypericum perforatum, Kali carbonicum, Lachesis mutus, Lathyrus sativus, Lilium tigrinum, Magnesia phosphorica, Nux vomica, Rhus toxicodendron, Silicea, Stramonium, Veratrum viride, Elaps
  • Active Ingredient(s): 15 [hp_X]/mL BRYONIA ALBA ROOT; 15 [hp_X]/mL CITRULLUS COLOCYNTHIS FRUIT PULP; 15 [hp_X]/mL CONVALLARIA MAJALIS; 15 [hp_X]/mL COPPER; 15 [hp_X]/mL CROTALUS HORRIDUS HORRIDUS VENOM; 15 [hp_X]/mL DATURA STRAMONIUM; 15 [hp_X]/mL DIGITALIS; 6 [hp_X]/mL ECHINACEA, UNSPECIFIED; 15 [hp_X]/mL GELSEMIUM SEMPERVIRENS ROOT; 15 [hp_X]/mL HYPERICUM PERFORATUM; 15 [hp_X]/mL LACHESIS MUTA VENOM; 15 [hp_X]/mL LATHYRUS SATIVAS SEED; 15 [hp_X]/mL LILIUM LANCIFOLIUM WHOLE FLOWERING; 15 [hp_X]/mL MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; 30 [hp_X]/mL MICRURUS CORALLINUS VENOM; 15 [hp_X]/mL OYSTER SHELL CALCIUM CARBONATE, CRUDE; 15 [hp_X]/mL POTASSIUM CARBONATE; 15 [hp_X]/mL SILICON DIOXIDE; 15 [hp_X]/mL SILVER NITRATE; 15 [hp_X]/mL STRYCHNOS NUX-VOMICA SEED; 15 [hp_X]/mL TOXICODENDRON PUBESCENS LEAF; 15 [hp_X]/mL VERATRUM VIRIDE ROOT
  • Administration Route(s): ORAL
  • Dosage Form(s): LIQUID
  • Pharmacy Class(es): Allergens [CS]; Calculi Dissolution Agent [EPC]; Cell-mediated Immunity [PE]; Copper [CS]; Copper-containing Intrauterine Device [EPC]; Decreased Embryonic Implantation [PE]; Decreased Sperm Motility [PE]; Increased Histamine Release [PE]; Increased IgG Production [PE]; Increased Large Intestinal Motility [PE]; Inhibit Ovum Fertilization [PE]; Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]; Inhibition Small Intestine Fluid/Electrolyte Absorption [PE]; Magnesium Ion Exchange Activity [MoA]; Non-Standardized Plant Allergenic Extract [EPC]; Osmotic Activity [MoA]; Osmotic Laxative [EPC]; Plant Proteins [CS]; Seed Storage Proteins [CS]; Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]

Labeler Information

Field Name Field Value
Labeler Name: Newton Laboratories, Inc.
Product Type: HUMAN OTC DRUG
FDA Application Number:
Marketing Category: UNAPPROVED HOMEOPATHIC
Start Marketing Date:1/1/2019

Package Information

No. Package Code Package Description Billing Unit
155714-2473-130 mL in 1 BOTTLE, GLASS (55714-2473-1)

NDC Record

Field Name Field Value Definition
PRODUCT NDC55714-2473The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
PRODUCT TYPE NAMEHUMAN OTC DRUGIndicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.
PROPRIETARY NAMELeg Cramps-SwellingThe proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.
NON PROPRIETARY NAMEEchinacea, Argentum nitricum, Bryonia, Calcarea carbonica, Colocynthis, Convallaria majalis, Crotalus horridus, Cuprum metallicum, Digitalis , Gelsemium sempervirens, Hypericum perforatum, Kali carbonicum, Lachesis mutus, Lathyrus sativus, Lilium tigrinum, Magnesia phosphorica, Nux vomica, Rhus toxicodendron, Silicea, Stramonium, Veratrum viride, ElapsThe non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.
DOSAGE FORM NAMELIQUIDThe translation of the dosage form Code submitted by the firm.
ROUTE NAMEORALThe translation of the route code submitted by the firm, indicating route of administration.
START MARKETING DATE1/1/2019This is the date that the labeler indicates was the start of its marketing of the drug product.
MARKETING CATEGORY NAMEUNAPPROVED HOMEOPATHICProduct types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
LABELER NAMENewton Laboratories, Inc.Name of Company corresponding to the labeler code segment of the Product NDC.
SUBSTANCE NAMEBRYONIA ALBA ROOT; CITRULLUS COLOCYNTHIS FRUIT PULP; CONVALLARIA MAJALIS; COPPER; CROTALUS HORRIDUS HORRIDUS VENOM; DATURA STRAMONIUM; DIGITALIS; ECHINACEA, UNSPECIFIED; GELSEMIUM SEMPERVIRENS ROOT; HYPERICUM PERFORATUM; LACHESIS MUTA VENOM; LATHYRUS SATIVAS SEED; LILIUM LANCIFOLIUM WHOLE FLOWERING; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; MICRURUS CORALLINUS VENOM; OYSTER SHELL CALCIUM CARBONATE, CRUDE; POTASSIUM CARBONATE; SILICON DIOXIDE; SILVER NITRATE; STRYCHNOS NUX-VOMICA SEED; TOXICODENDRON PUBESCENS LEAF; VERATRUM VIRIDE ROOTAn active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.
ACTIVE NUMERATOR STRENGTH15; 15; 15; 15; 15; 15; 15; 6; 15; 15; 15; 15; 15; 15; 30; 15; 15; 15; 15; 15; 15; 15 
ACTIVE INGRED UNIT[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL 
PHARM CLASSESAllergens [CS], Calculi Dissolution Agent [EPC], Cell-mediated Immunity [PE], Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased Large Intestinal Motility [PE], Inhibit Ovum Fertilization [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Non-Standardized Plant Allergenic Extract [EPC], Osmotic Activity [MoA], Osmotic Laxative [EPC], Plant Proteins [CS], Seed Storage Proteins [CS], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE] 

Download Record

Download this NDC record record in Text format: Export

Download this NDC record record in Excel (CSV) format: Export

Download this NDC record record in XML format: Export

This page was last updated on: 11/21/2025

Previous Code
Next Code